Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 1/1998

01-01-1998 | Leading Article

Combined Opioid-NMDA Antagonist Therapies

What Advantages Do They Offer for the Control of Pain Syndromes?

Author: Professor Zsuzsanna Wiesenfeld-Hallin

Published in: Drugs | Issue 1/1998

Login to get access
Metadata
Title
Combined Opioid-NMDA Antagonist Therapies
What Advantages Do They Offer for the Control of Pain Syndromes?
Author
Professor Zsuzsanna Wiesenfeld-Hallin
Publication date
01-01-1998
Publisher
Springer International Publishing
Published in
Drugs / Issue 1/1998
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-199855010-00001

Other articles of this Issue 1/1998

Drugs 1/1998 Go to the issue

Disease Management

Management of Malignant Pleural Effusions

Adis Drug Evaluation

Zafirlukast

Disease Management

Management of Cytomegalovirus Infection after Solid-Organ or Stem-Cell Transplantation

Disease Management

Recognition and Management of IgA Nephropathy

Disease Management

Practical Considerations and Guidelines for the Management of Community-Acquired Pneumonia

Review Article

The Taxoids